The present invention relates to linker molecules that readily conjugate cellular recognition ligand at one end and drug payload at the other, and are useful in treating or preventing cancer, an autoimmune disease, an inflammatory condition, a central nervous system disorder or an infection. The linker inker molecules of the invention are represented by Formula I, II and III; Linker-Drug compounds represented by Formula IV, V and VI; and Ligand-Linker-Drug conjugates represented by Formula VII, VIII and IX:
[EN] THIOL-ENE CLICK CHEMISTRY FOR DRUG CONJUGATES<br/>[FR] CHIMIE CLICK DES THIOL-ÈNES POUR CONJUGUÉS DE MÉDICAMENTS
申请人:SYNCHEM INC
公开号:WO2013181597A2
公开(公告)日:2013-12-05
The present invention relates to linker molecules that readily conjugate cellular recognition ligand at one end and drug payload at the other, and are useful in treating or preventing cancer, an autoimmune disease, an inflammatory condition, a central nervous system disorder or an infection. The linker inker molecules of the invention are represented by Formula (I), (II) and (II)I; Linker- Drug compounds represented by Formula (IV), (V) and (VI); and Ligand-Linker-Drug conjugates represented by Formula (VII), (VIII) and (IX):
THIOL-ENE CLICK CHEMISTRY FOR DRUG CONJUGATES
申请人:SYSCHEM, INC.
公开号:US20130323169A1
公开(公告)日:2013-12-05
The present invention relates to linker molecules that readily conjugate cellular recognition ligand at one end and drug payload at the other, and are useful in treating or preventing cancer, an autoimmune disease, an inflammatory condition, a central nervous system disorder or an infection. The linker inker molecules of the invention are represented by Formula I, II and III; Linker-Drug compounds represented by Formula IV, V and VI; and Ligand-Linker-Drug conjugates represented by Formula VII, VIII and IX: